Photys Therapeutics, Inc.
Founded 2021 · 4 known investors
Photys Therapeutics is a proximity-based drug developer working on targeted protein modulation medicines using its PHICS and tPRIME platforms alongside PROTAC expertise. It is building a pipeline of therapies for autoimmune, inflammatory, oncology, and cardiometabolic diseases, led by PHT-776, an oral IRAK4-targeted PROTAC in clinical development.
BiotechLongevity
Investors · 4
In the news
Frequently asked questions
- What does Photys Therapeutics, Inc. do?
- Photys Therapeutics is a proximity-based drug developer working on targeted protein modulation medicines using its PHICS and tPRIME platforms alongside PROTAC expertise. It is building a pipeline of therapies for autoimmune, inflammatory, oncology, and cardiometabolic diseases, led by PHT-776, an oral IRAK4-targeted PROTAC in clinical development.
- Who are Photys Therapeutics, Inc.'s investors?
- Photys Therapeutics, Inc.'s investors include Longwood Fund, MPM BioImpact, Ono Venture Investment, Inc., 8VC.